MedTrace Logo

Platelet-rich Plasma in the Treatment of Intractable Postherpetic Neuralgia

NCT05444413 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2022-09-08

No results posted yet for this study

Summary

used ultrasound-guided platelet rich plasma nerve block to treat Intractable Postherpetic Neuralgia.

Conditions

  • PHN - Post-Herpetic Neuritis

Interventions

BIOLOGICAL

ultrasound-guided platelet rich plasma nerve block

selected persons are treated by ultrasound-guided platelet rich plasma nerve block and the regular medicine

Sponsors & Collaborators

  • Affiliated Hospital of Nantong University

    lead OTHER

Principal Investigators

  • yuan zhou, doctor · Affiliated Hospital of Nantong University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-03
Primary Completion
2022-05-03
Completion
2022-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05444413 on ClinicalTrials.gov